The Nutshell

» cancer and funding

Daily News Roundup

Most Recent

image: Cancer Studies Seem Replicable

Cancer Studies Seem Replicable

By | June 27, 2017

In the latest findings from the Reproducibility Project: Cancer Biology, independent researchers achieve results that mirror those of two earlier papers.

0 Comments

image: Senators Bemoan Science Funding Cuts

Senators Bemoan Science Funding Cuts

By | June 23, 2017

At appropriations subcommittee hearings, President Trump’s budget proposal gets dissed by Republicans and Democrats.

1 Comment

image: Trump Picks National Cancer Institute Director

Trump Picks National Cancer Institute Director

By | June 12, 2017

Ned Sharpless currently leads the cancer center at the University of North Carolina, Chapel Hill.

0 Comments

image: Gene Mutations Foretell Immunotherapy Response

Gene Mutations Foretell Immunotherapy Response

By | June 12, 2017

A drug that blocks an immune checkpoint protein effectively treats tumors in patients with deficient DNA repair genes. 

0 Comments

image: Proposed NIH Grant Cap Criticized

Proposed NIH Grant Cap Criticized

By | June 8, 2017

Update: The agency announced it will ditch the proposal, and set up a fund for early- to mid-career scientists instead.

0 Comments

image: Age-Related Bias in NIH Awards

Age-Related Bias in NIH Awards

By | June 6, 2017

The number of young investigators with NIH grants has declined since 1982, but recent efforts by the agency to increase funding for early-stage investigators are working, a study finds.

0 Comments

The publicly available database found nearly a third of samples included mutations targeted by either approved drugs or therapies in clinical trials. 

0 Comments

Clinical medicine and biosciences are among the UK disciplines that receive the most EU funding.

0 Comments

National opinions about the effectiveness of last month’s science and climate marches are mixed and follow political lines, a Pew survey reports.

2 Comments

image: Zika's Economic Burden

Zika's Economic Burden

By | May 11, 2017

A new analysis estimates that the viral disease could cost between $183 million and more than $10 billion in the U.S. alone. 

1 Comment

Popular Now

  1. Man Receives First In Vivo Gene-Editing Therapy
  2. Researchers Build a Cancer Immunotherapy Without Immune Cells
  3. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

  4. Long-term Study Finds That the Pesticide Glyphosate Does Not Cause Cancer
RayBiotech